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PROBIOTIC STRAINS FOR SHELLFISH AQUACULTURE: PROTECTION
OF EASTERN OYSTER, CRASSOSTREA VIRGINICA, LARVAE AND JUVENILES
AGAINST BACTERIAL CHALLENGE
MURNI KARIM,1,4 WENJING ZHAO,2 DAVID ROWLEY,3 DAVID NELSON2 AND
MARTA GOMEZ-CHIARRI1*
1Department of Fisheries, Animal and Veterinary Sciences, University of Rhode Island, Kingston, RI
02881; 2Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881;
3Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston,
RI 02881; 4Department of Aquaculture, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
ABSTRACT Bacterial pathogens, including several Vibrio spp. and Roseovarius crassostreae, cause severe mortality of larval
and juvenile eastern oysters. The introduction of beneﬁcial bacterial isolates in oyster hatcheries and nurseries for the biocontrol
of bacterial diseases is a good alternative to the use of antibiotics. The goal of this study was to screen and characterize marine
bacterial isolates as potential agents to prevent larval and juvenile mortality by the oyster pathogens Vibrio tubiashii and
R. crassostreae. Screening of bacterial isolates from Rhode Island marine organisms and environment using agar-based assay
methods for detection of antimicrobial activity against oyster pathogens led to the isolation of candidate probionts Phaeobacter
sp. S4 and Bacillus pumilusRI06-95. Pretreatment of larval and juvenile oysters for 24 h with 102–106 cfu/mL Phaeobacter sp. S4
or B. pumilus RI06-95 protected larval oysters against mortality resulting from challenge with R. crassostreae and V. tubiashii
(relative percent survival (RPS) range, 9%–56%). These probiotics also protected juvenile oysters against challenge with
V. tubiashii (RPS, 37%–50%). Probiotic isolates had no negative impact on oyster survival. Protection conferred to larvae against
bacterial challenge was short-lived, lasting for only 24 h after removal of the probiotics from the incubation water. These results
suggest the potential ofmarine bacterial isolatesPhaeobacter sp. S4 andB. pumilusRI06-95 to serve as biocontrol agents to reduce
the impact of bacterial pathogens in the culture of Crassostrea virginica.
KEYWORDS: oyster larvae, oyster juveniles, probiotic bacteria, Roseovarius oyster disease, shellﬁsh hatchery, shellﬁsh nursery,
vibriosis, Vibrio tubiashii, Crassostrea virginica
INTRODUCTION
The eastern oyster, Crassostrea virginica (Gmelin), a bivalve
species of the Gulf of Mexico and Atlantic coasts of North
America, has signiﬁcant economic and ecological value (Kennedy
et al. 1996). However, this species suffers from the impact of
different bacterial and parasitic diseases that cause high mor-
talities in cultured and wild populations (Lee et al. 1996,
Burreson & Ford 2004, Villalba et al. 2004). Bacterial infections
are considered a major problem for the shellﬁsh aquaculture
industry and cause mass mortality, especially during the larval
and juvenile stages (Paillard et al. 2004). The pathogens Rose-
ovarius crassostreae and several Vibrio spp. are among the
major causative agents of bacterial disease in the culture of the
eastern oyster. As the causative agent of juvenile orRoseovarius
oyster disease, R. crassostreae causes high seasonal mortalities
of oyster juveniles in the Northeast Unites States (Boettcher
et al. 2005, Maloy et al. 2007). Meanwhile, Vibrio tubiashii is
a reemerging pathogen that causes vibriosis and severe losses of
production in oysters during the larval stages (Tubiash et al.
1965, Elston et al. 2008).
Disease outbreaks in shellﬁsh aquaculture are managed
using methods such as disease avoidance, frequent water
changes, good husbandry, and the use of immunostimulants
and antibiotics (Elston & Ford 2011). Antibiotics have been
used widely in aquaculture systems as a method for disease
control. However, because of the emergence of antibiotic resis-
tance and concerns about environmental pollution, alternatives
to the use of antibiotics are needed (Austin 1985, Verschuere et al.
2000). One of these alternative methods is the use of nonpatho-
genic microorganisms called probiotics.
A probiotic is generally deﬁned as a live microbial food
supplement that, when administered in a sufﬁcient amount,
confers a health beneﬁt on the host (Food and Agricultural
Organization of the United States 2006). In aquaculture, pro-
biotics can be administered either as a food supplement or as an
additive to the water (Moriarty 1998). Probiotics in aquaculture
have been proposed to have several modes of action: improve-
ment of water quality, enhancement of immune responses of
host species, enhancement of nutrition of host species through
the production of supplemental digestive enzymes, competition
for space with pathogenic bacteria, and production of antimi-
crobial compounds (Thompson et al. 1999, Verschuere et al.
2000, Kesarcodi-Watson et al. 2008). The potential for the
beneﬁcial impact of the use of probiotic bacteria on shellﬁsh
aquaculture has been shown for many different species, in-
cluding oysters. Douillet and Langdon (1994) demonstrated
that Paciﬁc oyster larvae fed with algae and Alteromonas sp.
show increased survival and growth compared with treatments
fed with algae alone. They suggest that the bacteria may act as
an essential nutrient to the larvae, which is not provided by the
algae. Gibson et al. (1998) isolated successfully a bacterium
producing bacteriocin-like inhibitory substances capable of
inhibiting the growth of several pathogenic bacteria. This
probiont, identiﬁed as Aeromonas media A199, inhibits signif-
icantly the growth of Vibrio tubiashii in the culture of Paciﬁc
oyster larvae. The addition of Vibrio sp. probiotic candidate
OY15 provides a beneﬁcial effect in the culture of Crassostrea
virginica larvae with and without the presence of the shellﬁsh
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pathogen Vibrio sp. B183 (Kapareiko et al. 2011). Most re-
cently, the use of Pseudoalteromonas sp. D41 and Phaeobacter
gallaeciensis was found to provide 50% and 40% improved
survival, respectively, in Paciﬁc oyster larvae after being
challenged with Vibrio coralliilyticus (Kesarcodi-Watson et al.
2012). The introduction of selected beneﬁcial bacterial isolates
for biocontrol of Roseovarius crassostreae and vibriosis may
help in combating diseases in the culture of eastern oysters.
In this study, 2 potential probionts were isolated from 2
different local sources in Rhode Island. A Gram-negative
Phaeobacter sp. S4 was isolated from the inner shell of oysters
and a Gram-positive Bacillus pumilus RI06-95 was isolated
from a marine sponge from Narrow River, a tidal estuary in
Narragansett, Rhode Island. Both of these candidate probionts
showed promising results during in vitro screening of antibiotic
activity against oyster and ﬁsh pathogens, and protected larvae
and juveniles during in vivo challenge experiments with 2
bacterial pathogens (Vibrio tubiashii RE22 and Roseovarius
crassostreae CV919-312T). We also describe the length of the
protection conferred by the probiotic treatment.
MATERIALS AND METHODS
Bacterial Strains
Bacterial strains Vibrio tubiashii RE22 (Hasegawa et al.
2008) and Roseovarius crassostreae CV919-312T (Boettcher
et al. 2005) were kindly supplied by H. Hasegawa (Depart-
ment of Biomedical Sciences, Oregon State University) and
K. Boettcher (formerly at the University of Maine), respec-
tively. Strain Vibrio harveyi BB120 (Bassler et al. 1997) was
obtained from B. Bassler (Princeton University). The marine
bacteria Phaeobacter sp. S4 and Bacillus pumilus RI06–95 were
identiﬁed as potential probiotics using the in vitro plate assays
described later. The isolates were characterized to the level of
species using 16S rDNA sequence analysis (Gauger & Go´mez-
Chiarri 2002) (GenBank accession nos. KC625490 and
KC625491). All the isolates were maintained and stored in
50% glycerol stocks at –80C. Probiotic candidates and patho-
gens were grown routinely overnight in yeast peptone with 3%
NaCl (YP3) broth (5 g/L peptone, 1 g/L yeast extract, 30 g/L
ocean salt, Instant Ocean) at 28C (V. tubiashii, V. harveyi, and
R. crassostreae) or 25C (B. pumilus RI06-95) with shaking.
In Vitro Screening of Probiotic Candidates
A bacterium–bacterium competition assay described by
Teasdale et al. (2009) was used in this assay with several mod-
iﬁcations. In the colony-on-top assay, 5mL 0.8%ofYP3 soft agar
containing 50 mL of approximately 108 cfu/mL of the pathogen
from an overnight culture was poured over YP3 agar plates. After
the agar cooled, 2 mL of a solution of about 108 cfu/mL of the
candidate probiotic from an overnight culture was spotted onto
the plate and incubated at 30C for 12–16 h before the inhibi-
tion zones were measured. For the membrane overlay assay, an
aliquot of 2 mL of a solution of approximately 108 cfu/mL of the
candidate probiotic was spotted onto YP3 agar plates and in-
cubated at 23C for 48 h. After incubation, a sterile 12–14 kDa
molecular-weight cutoff dialysis membrane (Spectra/Por; Spec-
trum Medical Industries, Inc., Houston, TX) was laid atop the
colonies and coveredwith 6mL 0.8%YP3 agar containing 60 mL
of approximately 108 cfu/mL of pathogen from an overnight
culture. Plates were incubated at 30C for 12–16 h after agar
solidiﬁcation, and the diameter of the clear (inhibitory) zones
around the probiont colonies was measured using a ruler.
Characterization of Phaeobacter sp. S4 Growth and Morphology
Single colonies of Phaeobacter sp. S4 were inoculated onto
YP3 media, grown for 48 h at 27C with shaking, and then
back-diluted into fresh YP + 2%NaCl (YP2) or YP + 3%NaCl
(YP3) media at a 1:1,000 dilution. Cultures were incubated at
27C with shaking for up to 72 h, and aliquots were taken at
selected time points to determine bacterial concentration (mea-
sured in colony-forming units per milliliter) by plating of serial
dilutions. Aliquots of bacterial cells taken from cultures grown
to late exponential (36 h) and stationary (48 h) phases were
placed on glass coverslips and examined by phase-contrast
microscopy at the Rhode Island Genomics and Sequencing
Center at the University of Rhode Island with a Zeiss Axio
Imager 2 microscope using phase-contrast optics. Bioﬁlm-
containing samples were grown in static culture conditions for
48 h at 27C and scraped from the walls of the glass culture
tubes (15 3 150 mm) before being placed on glass slides and
observed by phase-contrast microscopy.
Preparation of Bacterial Isolates for Challenge
Candidate probiotics and pathogens were cultured over-
night with shaking in 10mLYP3 broth. Overnight cultures were
transferred to 50-mL sterile Falcon tubes and centrifuged at
2,300g for 10 min to harvest the cells. Cells were washed twice
with 10 mL ﬁltered sterile seawater (FSSW) and the cell pellet
was resuspended in 10 mL FSSW and mixed using a vortex
mixer. The bacterial density was determined by measuring
optical density at 550 nm using a spectrophotometer (Synergy
HT; BioTek) and assuming that an optical density of 1.000
corresponds to 1.23 109 cfu/mL according to the McFarland
standard (BioMerieux, MarcylEtoile, France). After the con-
centration of the bacteria was determined, the bacterial sus-
pension was diluted to the target concentration in FSSW. The
ﬁnal target concentration was conﬁrmed by plating serial
dilutions of the bacterial cultures for each treatment on the
appropriate agar plates and counting colony forming units after
overnight incubation at 25C or 28C. The commercial pro-
biotic mix (Sanolife MIC; INVE Aquaculture, Belgium) was
mixed by adding 0.1 g Sanolife to 50 mL FSSW following the
manufacturers protocol. The solution was then adjusted to
a stock concentration of 53 106 cfu/mL and used at a target
concentration of 104 cfu/mL.
Larval Oyster Bacterial Challenges
Experimental challenges were performed as described pre-
viously (Go´mez-Leo´n et al. 2008) with minor modiﬁcations.
Larvae of eastern oysters, Crassostrea virginica (age, 12–20 days;
size, 50–150 mm) were obtained from the Blount Shellﬁsh
Hatchery at Roger William University (Bristol, RI). Oysters
(25–30 larvae) were placed in each well of a 6-well plate
containing 5 mL FSSW at 28 psu. The candidate probiotics
isolates S4 and RI06-95 were added to the wells at ﬁnal
concentrations ranging from 102–106 cfu/mL. The commercial
probiotic Sanolife MIC was used at a ﬁnal concentration of
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104 cfu/mL. Larval oysters were fed with commercial algal paste
(20,000 cells/mL; Reed Mariculture Inc., San Jose, CA) to
promote ingestion of the probiotics. Plates were incubated at
22–23C for 24 h with gentle rocking. Water in the wells was
then changed to remove the probiotics. Either Vibrio tubiashii
RE22 or Roseovarius crassostreae CV919-312T was added to
5 mL FSSW containing the larvae to achieve the target con-
centration of pathogen (105 cfu/mL or 106 cfu/mL). Control
wells included untreated larvae (with and without pathogen)
and larvae incubated with probiotics but not with the pathogen.
Each treatment was run in triplicate. Larval survival was
determined 24 h after addition of the pathogen by adding
200 mL neutral red to each well to a ﬁnal concentration of
0.53 mg/L and incubating for 2 h before counting living and
dead oysters. The neutral red staining technique distinguishes
between live (stained) and dead (unstained) larvae (Fig. 1)
(Go´mez-Leo´n et al. 2008). The survival rate was calculated by
using the formula
Survival rate ð%Þ ¼ 1003 No: of live larvae
Total no: of larvae
 
:
The relative percent survival (RPS) (Amend 1981) conferred by
the probiont (treatment) with respect to the challenged larvae
(control) was calculated by using the formula
RPS ¼ 1 % Mortality treatment
% Mortality control
  
3 100:
These experiments were run at least 3 times in triplicate for the
candidate probionts S4 and RI06–95, and once for the com-
mercial probiont Sanolife MIC.
Length of Protection Conferred by Candidate Probionts
Larval oysters were placed in 6-well plates containing 5 mL
FSSW; candidate probionts were introduced to a ﬁnal concen-
tration of 104 cfu/mL. Plates were incubated at 22–23C for 24 h
with gentle rocking. At 24 h of incubation, FSSW was removed
from the wells and exchanged with 5 mL FSSW without the
probiotics. The pathogen Vibrio tubiashii RE22 (ﬁnal concen-
tration, 105 cfu/mL) was applied to the wells 24 h, 72 h, or 120 h
after addition of the candidate probionts (equivalent to 0 h,
48 h, or 96 h after removal of the probiont). After 24 h of
incubation with the pathogen, larval oyster survival and RPS
were determined as described earlier. Larval oysters were fed
daily with commercial algal paste (20,000 cells/mL). This assay
was run only once with each treatment tested in triplicate.
Juvenile Oyster Bacterial Challenges
Ten juvenile oysters (shell height, 8–15 mm) per container
were placed in 500-mL buckets containing 200 mL FSSW, and
each container was provided with continuous aeration via air
stones. Candidate probionts were applied at a ﬁnal concentra-
tion of 105 cfu/mL and containers were incubated at 22–23C
for the length of the experiment. After 24 h of incubation with
the probiont, Vibrio tubiashii RE22 was applied to a ﬁnal
concentration of 105 cfu/mL. Mortalities were recorded every
2–3 days for 13 days, and cumulative percent survival was
calculated.Water was exchanged every 2–3 days and the oysters
were fed daily with commercial algal paste (20,000 cells/mL).
This experiment was performed once using duplicate containers
per treatment.
Statistical Analysis
Survival and cumulative mortality data were analyzed using
1- or 2-way analysis of variance (ANOVA), and multiple
comparison tests (Tukeys test) was used to determine signiﬁ-
cance among groups. Data collected as a percentage were
arcsine of the square root-transformed before analysis. Results
were considered signiﬁcant at a 95% level of conﬁdence (P <
0.05). All statistics were run using SigmaStat 3.1 software
(Systat).
RESULTS
Antibiotic Activity Against Bacterial Pathogens
In this study, among 64 bacteria strains isolated from the
inner shell of healthy oysters, only Phaeobacter sp. S4 was
found to have antibiotic activity against Vibrio harveyi BB120
by using 2 different plates assays. In the membrane overlay
assay, the use of the membrane prevents direct contact between
probiont and pathogen, only allowing chemicals with a molec-
ular mass less than 12–14 kDa to go through. This method
allows observation of chemical interactions between probiont
and pathogen. Meanwhile, the colony-on-top assay allows for
direct bacterial interaction between probiont and pathogen.
The probiont candidate Bacillus pumilus RI06-95 inhibited the
growth of pathogensV. harveyiBB120 at 28C andRoseovarius
crassostreae CV919-312T at 20C and 28C using both the
colony-on-top and the membrane overlay assays (Table 1). This
isolate, however, showed no growth-inhibiting activity against
Figure 1. Effect of preincubation with candidate probiontPhaeobacter sp.
S4 on the morphology of larval oysters 24 h after challenge with the
bacterial pathogen Vibrio tubiashii RE22. The candidate probionts were
introduced 24 h before pathogen challenge. (A) Larva challenged with
RE22 show clumping of cilia (arrow). (B) Group of larva challenged with
RE22 show cell debris (thick arrow) and dead larvae as indicated by empty
shells not stained with neutral red (arrow). (C, D) Larvae preincubated
with S4 and challenged with RE22 were viable and show staining with
neutral red (arrow) and normal cilia (arrowhead).
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Vibrio tubiashii RE22. The candidate probiont Phaeobacter sp.
S4 inhibited the growth of all pathogens with the exception of
V. tubiashii RE22 at 20C in the colony-on-top assay (Table 1).
Differences in the pattern of inhibition between the 2 assays for
this probiont are probably the result of differences in the length
of the incubation times of the probiotic with the pathogen (12–
16 h for the colony on top and 48 h for the membrane overlay).
Characterization of Phaeobacter sp. S4 Growth and Morphology
We characterized Phaeobacter sp. S4 with regard to some
basic properties that might affect its ability to serve as a pro-
biotic organism in marine aquaculture—namely, growth curves
in marine media and the ability to form bioﬁlms. Brieﬂy, S4
grew well in YP2 or YP3 at temperatures from 18–30C (not
shown). Cells were unable to grow at 37C. At 27C, there was
no difference in the growth rate of S4 when cells were grown in
either YP2 or YP3 (Fig. 2). The fastest doubling times for the
cells in YP2 and YP3 were 2.2 h and 1.9 h, respectively. The
average doubling time for each condition was 3.1 h for YP2
and 3.2 h for YP3. The ﬁnal density of S4 in either YP2 or YP3
was more than 2.03109cfu/mL.
Although growth in YP2 and YP3 produces virtually
identical growth rates and ﬁnal cell densities, these 2 conditions
resulted in 2 different morphologies for Phaeobacter sp. S4
(Fig. 3). Growth in YP3 resulted in small, ovoid, motile cells
(Fig. 3A) that, when entering the stationary phase, form
rosettes. Cells grown in YP2 elongate to spindle-shaped cells
during the late stationary phase, lose motility, and form rosettes
(Fig. 3B, C). If grown in static culture, the cells formed a thick
bioﬁlm on glass surfaces (Fig. 3D). Plastic surfaces (polycar-
bonate, polystyrene, and polypropylene) did not support the
formation of a bioﬁlm by S4 (not shown).
Effect of Pretreatment with Probiotics on Larval Oyster Survival of
Bacterial Challenge
Candidate probionts were not pathogenic to the host
because the survival of oyster larval treated with the candidate
probionts was not signiﬁcantly different from the control (Fig.
4). Rapid deaths of larval oysters were seen after exposure to
pathogens Vibrio tubiashii RE22 and Roseovarius crassostreae
CV919-312T for 24 h, with survival ranging from 14%–31%,
depending on the pathogen and dose (>80% for unchallenged
controls). Survival of oysters pretreated with candidate pro-
bionts for 24 h and then exposed to the bacterial pathogens were
signiﬁcantly greater than those larvae that had not been
exposed to the probiont, increasing from a survival of 14%–
31% for untreated larvae to 32%–64% for probiotic-treated
larvae (Fig. 4).
The level of protection was different depending on the
relative concentrations of candidate probionts and pathogen
added (Table 2). Candidate probiont Phaeobacter sp. S4 was
found to protect larval oysters more effectively against Vibrio
tubiashii RE22 than against Roseovarius crassostreae CV919-
312T. This study also demonstrated Phaeobacter sp. S4 gave
greater levels of protection against both pathogens thanBacillus
pumilus RI06-95. The optimal concentration for probionts
Figure 2. Growth curve of Phaeobacter sp. S4 in YP2 and YP3 at 278C.
Cells were grown for 48 h in YP3 and then back-diluted into fresh YP2 (4)
or YP3 (n) at a 1:1,000 dilution. Samples were taken at the indicated times
and the cell density was determined by serial dilution and plating onto
YP3.
TABLE 1.
Antibiotic activity of candidate probionts Phaeobacter sp. S4
and Bacillus pumilus RI06-95 against selected bacterial
pathogens of ﬁnﬁsh (Vibrio harveyi BB120) and shellﬁsh
(Vibrio tubiashii RE22 and Roseovarius crassostreae
CV919-312T) as determined by 2 plate diffusion assays
at 2 temperatures.
Probiotic,
temperature
Colony on top (mm) Membrane overlay (mm)
BB120 RE22 CV919-312T BB120 RE22 CV919-312T
RI06-95,
20C
— 0 11 ± 1 — 0 4 ± 1
RI06-95,
28C
10 ± 1 0 13 ± 1 7 ± 1 0 5 ± 1
S4 20C — 0 16 ± 0 — 6 ± 1 15 ± 1
S4, 28C 6 ± 1 7 13 ± 1 6 ± 1 6 ± 1 13 ± 2
The antibiotic activity is reported as the diameter of the inhibition zone
in millimeters ± SEM, including the size of the colony for the candidate
probiont (3 mm). —, not tested
Figure 3. Phase contrast micrographs showing the morphology of
Phaeobacter sp. S4 in different growth phases. (A) Late-exponential
phase cells grown in YP3. (B) Late-exponential phase cells grown in YP2.
(C) YP2-grown cells in rosettes. (D) S4 cells grown in YP2 in a bioﬁlm.
Size bar$ 10 mm.
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Phaeobacter sp. S4 and B. pumilus RI06-95 was 104 cfu/mL. At
this concentration, both probiotics were able to confer sig-
niﬁcant survival against V. tubiashii RE22 (P < 0.05) and
R. crassostreae CV919-312T (Table 2). On the other hand,
no protection effect was found in larval oysters treated with
commercial probiotic Sanolife MIC after challenge with
V. tubiashii RE22 (survival of challenged larvae pretreated
with Sanolife MIC of 2 ± 2% compared with 98 ± 2% for
unchallenged larvae pretreated with Sanolife MIC; Table 2).
Length of Protection Conferred by Probiotics
To determine the duration of protection provided by a 24-h
exposure of larval oysters to the candidate probionts, we
determined the survival of larval oysters challenged at different
time points after exposure to the probionts (0 h, 48 h, and 96 h
after removal of the candidate probionts). As observed earlier,
larval oysters incubated with probionts for 24 h were protected
signiﬁcantly against a 24-h bacterial challenge with Vibrio
tubiashii when the pathogen was added immediately after the
removal of the probiont (Fig. 5). However, no signiﬁcant
protection was obtained when the larvae were challenged 48 h
and 96 h after removal of the probionts. The RPS of larval
oysters exposed to Phaeobacter sp. S4 for 24 h decreased
signiﬁcantly, from 78% when oysters were challenged immedi-
ately after removal of the probiont to 14% and 13% when
oysters were challenged 48 h and 96 h, respectively, after
removal of the probiont. The RPS of larval oysters exposed
to Bacillus pumilus RI06-95 decreased from 44% when oysters
were challenged right after removal of the probiont to 1%
(challenged at 48 h) and 4% (challenged at 96 h).
Effect of Pretreatment with Probionts on Juvenile Oyster Survival of
Bacterial Challenge
We wanted to determine whether exposure to the probiotic
bacteria would protect juvenile oysters from Vibrio tubiashii
in a manner similar to what was observed for larval oysters.
Although juvenile oysters showed a sharp increase inmortalities
on day 6 after challenge with V. tubiashii RE22, oysters in
containers to which probiotic strains were added 24 h before the
challenge showed relatively low levels of mortality (<15%) until
day 8 after challenge (Fig. 6). At the end of the assay (13 days),
exposure to the probionts reduced signiﬁcantly juvenile oyster
mortalities after challenge with V. tubiashii (P < 0.05; RPS:
B. pumilusRI06-95, 60 ± 0%; Phaeobacter sp. S4, 67 ± 0%). Co-
incubation of juvenile oysters with both S4 and RI06-95 did not
confer added levels of protection compared with preincubation
with either one of the probiotics alone (P > 0.05).
DISCUSSION
This study identiﬁed successfully 2 potential bacterial can-
didates to be used as probiotics for disease management control
in oyster aquaculture. Bacterial strains Phaeobacter sp. S4 and
Bacillus pumilus RI06-95 were selected as candidate probionts
because of their antagonistic properties against the oyster
Figure 4. Effect of preincubation of larval oysters with candidate
probionts RI06-95 and S4 at 104 cfu/mL on survival (% % SEM) 24 h
after challenge with bacterial pathogensRoseovarius crassostreaeCV919-
312T and Vibrio tubiashii RE22 at 105 cfu/mL. The candidate probionts
were introduced 24 h before larvae were challenged. Representative of at
least 3 experiments; different letters indicate statistical signiﬁcance
among groups (1-way ANOVA, P < 0.05).
TABLE 2.
Effect of preincubation with candidate probionts Bacillus pumilus RI06-95, Phaeobacter sp. S4, and commercial probiotic mix
Sanolife MIC (INVE Aquaculture, Belgium) on larval oyster survival 24 h after challenge with bacterial pathogens Roseovarius
crassostreae CV919-312T and Vibrio tubiashii RE22.
Relative percent survival*
Probiotics and concentration (cfu/ml)
RI06-95 S4 INVE
Bacterial pathogens and concentration (cfu/mL) 106 104 102 106 104 102 106
Oyster
RE22
106 31 ± 2a — — 53 ± 3b — — —
105 29 ± 3a 29 ± 3a — 44 ± 3b 55 ± 2b — 0
CV919–312T
106 11 ± 2x — — 14 ± 3x — — —
105 22 ± 2y 42 ± 3z 20 ± 1xy 43 ± 5z 49 ± 3z 29 ± 2y —
The candidate probionts were introduced 24 h before larvae were challenged. Data are expressed as relative percent survival (±SEM) of challenged
oysters pretreated with probiotic to control challenged oysters. Different letters in superscript indicate statistical differences among treatments for
each probiont (1-way ANOVA, P < 0.05).
* RPS ¼ 1 % Mortality treatment
% Mortality control
  
3 100: —, not tested.
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pathogens Roseovarius crassostreae and Vibrio tubiashii, and
also themarine ﬁnﬁsh and shellﬁsh pathogenVibrio harveyi. We
demonstrate here that they also conferred signiﬁcant protection
to larval oysters against experimental bacterial challenge.
Furthermore, preincubation of juvenile oysters with these
probionts led to signiﬁcantly improved survival of juvenile
oysters 13 days after challenge with V. tubiashii.
These 2 candidate probionts were able to protect oyster
larvae and juveniles against the severe bacterial challenges used
in our research, and show the potential to provide protection
when used prophylactically in hatcheries, where the levels of
pathogenic bacteria in seawater sometimes approach levels
similar to the challenge doses used in our experiments (Elston
et al. 2008). The bacterial pathogens Vibrio tubiashii and
Roseovarius crassostreae caused rapid mortalities in larval
oysters in our experiments; oysters stopped swimming andmost
of the tissue was digested completely, leaving an empty shell
after 24 h of exposure to the pathogens. This is consistent with
previous research on these pathogens (Gibson et al. 1998,
Elston et al. 2008, Go´mez-Leo´n et al. 2008).
The candidate probionts we have tested here are commensals
of marine organisms and were proved in our experiments to be
safe to larval and juvenile oysters because they had no
signiﬁcant effect on larval or juvenile survival at the concentra-
tions tested (up to 106 cfu/mL). Although we have not tested the
effect of these probionts on algal cultures directly, previous
research on another Phaeobacter sp. (Phaeobacter gallaeciensis)
with probiotic activity on cod larval cultures showed no
negative effects of this probiont on the survival of the micro-
algae Tetraselmis suecica, a species used commonly in aquacul-
ture hatcheries (DAlvise et al. 2012). Our experiments also
showed that signiﬁcant levels of protection were obtained with
a dose of probiotic of 104 cfu/mL, a dose achieved easily even in
the large culture tanks used at commercial hatcheries. The
length of protection conferred to larval oysters by exposure to
the probionts, however, is short term (24 h), suggesting that
these probiotics may need to be supplied to larvae in the
hatcheries daily to maintain their effectiveness. This is not
uncommon for other probiotics, which are usually provided
daily with the feed to host organisms to provide maximum
beneﬁts (Verschuere et al. 2000, Kesarcodi-Watson et al. 2008).
Interestingly, a single dose of probiotics added to the culture
water of juvenile oysters 24 h prior to bacterial challenge
provided signiﬁcant levels of protection for at least 13 days,
suggesting that the probionts may persist longer in juvenile
oysters compared with larval oysters, or that additional mech-
anisms of protection are involved in juvenile oysters. More
research should be done to determine the effectiveness and
mechanisms of action of these probiotic bacterial strains during
different developmental stages of oysters and different growing
conditions.
Our study showed that lack of growth-inhibiting activity in
vitro toward a particular pathogen is not necessarily predictive
of how a candidate probiont would perform in vivo. Candidate
probiont Bacillus pumilus RI06-95 was not able to inhibit the
growth of Vibrio tubiashii in vitro, but it showed a protective
effect toward larval and juvenile oysters during in vivo challenge,
suggesting that protection conferred by B. pumilus RI06-95
Figure 6. Effect of preincubation of juvenile oysters with candidate
probionts on oyster survival after bacterial challenge. Oysters were
preincubated with 104 cfu/mL of probionts Bacillus pumilus RI06-95 or
Phaeobacter sp. S4 for 24 h. Then, 105 cfu/mL of the pathogen Vibrio
tubiashii RE22 was added to the incubation seawater; survival was
determined every 2–3 days for 13 days. Different letters indicate statistical
signiﬁcance among treatments (1-way ANOVA, P < 0).
Figure 5. Length of protection to bacterial challenge provided by preincubation of larval oysters with candidate probionts RI06–95 and S4. Larval
oysters were preincubated for 24 with 104 cfu/mL probiont, washed, placed in ﬁltered sterile seawater, and then challenged by adding 105 cfu/mL of the
pathogenVibrio tubiashii RE22 0 h, 48 h, or 96 h after removal of the probionts. Different letters indicate statistical signiﬁcance among treatments and
times (2-way ANOVA, P < 0.05).
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against V. tubiashii may not be a result of antibiotic activity or
that the in vitro assays used in the screening process do not
predict the production of the antibiotic in vivo. Probiotics are
able to improve survival of the hosts by different mechanisms
(Verschuere et al. 2000, Kesarcodi-Watson et al. 2008). Beside
secretion of antibiotic compounds, it is known that probiotics
are capable of various other modes of action that give beneﬁts
to the host. In previous research, Bacillus sp. S11 has been
reported to improve health by stimulating the immunity of the
host organism (Rengpipat et al. 2000). This may be one of
potential mechanism provided by B. pumilusRI06-95 to protect
the oysters against V. tubiashii in our in vivo assay. This pro-
biotic may also promote enhanced digestion in oysters. Re-
search by Olmos et al. (2011) demonstrated the ability of
Bacillus subtilis to enhance carbohydrate digestion and improve
the health of shrimp (Litopenaeus vannamei). Furthermore, Sun
et al. (2010) demonstrated that grouper (Epinephelus coioides)
consumed dietary nutrients better after supplementing the feed
with B. pumilus or Bacillus clausii.
In contrast, the results from the in vitro tests with Phaeo-
bacter sp. S4 showed growth-inhibiting activity against the 2
oyster pathogens, and this coincided with increased protection
seen in the in vivo assays. Research performed by Porsby et al.
(2008) showed that members of the Roseobacter clade such as
Phaeobacter gallaeciensis and Phaeobacter inhibens produce an
antibiotic compound named tropodithietic acid, which is
capable of inhibiting the growth of the bacterial pathogens
Vibrio anguillarum, Vibrio splendidus, Vibrio cholerae, Bacillus
subtilis, and Halomonas spp. Furthermore, the application of
bacterial cultures or cell extracts of Phaeobacter spp. improve
survival of ﬁsh larvae (Makridis et al. 2005, Planas et al. 2006)
and shellﬁsh (Ruiz-Ponte et al. 1999, Balca´zar et al. 2006) in
rearing tanks. Recently, DAlvise et al. (2012) demonstrated the
ability of P. gallaeciensis to protect cod larvae from vibriosis.
Besides producing tropodithietic acid, Phaeobacter spp. are
known as primary colonizers of various inorganic and organic
marine surfaces, including marine algae and dinoﬂagellates
(Dang & Lovell 2002, Mayali et al. 2008). Our observations
of this bacterium conﬁrm thatPhaeobacter sp. S4 forms rosettes
and bioﬁlms avidly on inorganic surfaces, such as glass.
Furthermore, our results, which show the ability of a Phaeo-
bacter sp. isolated from the inner side of an adult oyster shell
(and probably a member of the natural oyster microbiome) to
protect larval oysters from bacterial challenge, provide further
evidence of the potential of Phaeobacter spp. as probiotic
species.
In conclusion, these studies successfully isolated 2 candi-
date probionts for disease management in oyster hatcheries.
The probiont Phaeobacter sp. S4 is a good probiont candidate
that showed clear antibiotic activity in vitro and protection in
vivo. The relationship between probiotic activity in vivo and
antibiotic activity in vitro, however, is not so strong in the case
of protection of larval oysters against Vibrio tubiashii con-
ferred by Bacillus pumilus RI06-95, suggesting that other
mechanisms contribute to probiotic activity. Thus, in addition
to good candidates for use in shellﬁsh aquaculture, these
candidate probionts will be useful in evaluating the relation-
ship between antibiotic and probiotic activities to help estab-
lish rational strategies for the screening for potential
probiotics.
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